Analyst Price Target is $6.33
▲ +45.76% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for (BIOA) in the last 3 months. The average price target is $6.33, with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 45.76% upside from the last price of $4.35.
Current Consensus is
Reduce
The current consensus among 4 investment analysts is to reduce stock in (BIOA). This rating has held steady since November 2024, when it changed from a Buy consensus rating.
BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.
Read More
